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background:  To evaluate role of contrast injection on patient discomfort (sensation of heat, pain or coldness) during peripheral arteriography.
methods:  In a prospective, multi-center, randomized, double-blind, comparative trial of Visipaque 320 mg I/mL versus Isovue 370 (iopamidol 
Injection 76%) for peripheral arteriography, patient discomfort was assessed within 10 minutes following each contrast injection and was rated 
verbally by the patient on a scale of 0 to 10 with score 0 as none, 1-3 mild, 4-7 moderate, and 8-10 severe. Multivariate logistic regression analysis 
was performed to identify independent contributing factors for patient discomfort.
results:  Visipaque was administered in 127 patients (mean age 62 years, 61% male) and isovue in 126 (mean age 63 years, 64% male) with 125 
in Visipaque and 124 in isovue group completed discomfort assessments. The logistical regression analysis with contrast type, age group, gender, 
diabetic status, use of sedation, and prior history of contrast usage, cardiovascular disease, or peripheral arterial diseases as covariates showed that 
contrast was a significant independent variable for patient discomfort: Visipaque injection contributed significantly less moderate/severe overall 
patient discomfort (OR = 0.29, p=0.005), heat (OR=0.46, p=0.0153), or pain (OR=0.10, p<0.0001) compared to Isovue. No difference was observed 
for other safety parameters between the two groups.
conclusion:  Contrast type is a significant independent contributing factor for patient discomfort with Visipaque administration during peripheral 
arteriography having significantly favorable patient comfort profile compared to Isovue injection.
